Bio-Rad Releases Nineteen Specialized Infrared Spectral Data Collections
News Feb 01, 2006
Bio-Rad Laboratories, Inc. has announced the release of nineteen high-quality infrared databases including: Alcohols and Phenols, Aldehydes, Amino Acids and Peptides, Anhydrides and Lactones, Carboxylic Acids, Dyes, Alkynes, and Azo Compounds, Esters, Explosive Materials, HAZMAT, Hydrocarbons and Halogenated Hydrocarbons, Hydrocarbons, Ketones, Nucleic Acids, Nucelosides, and Nucleotides, Organometallics, Inorganics, Silanes, Boranes, and Deuterium Compounds, Phosphorus Compounds, Polymeric Compounds, Steroids, Sugars and Carbohydrates, Sulfur Compounds.
With the addition of these databases, Bio-Rad now offers over 95 standalone IR spectral databases.
Bio-Rad's spectral databases are used by scientists worldwide in the verification, classification, identification of chemical substances across multiple areas of research, such as pharmaceutical, forensic, environmental, materials sciences, and polymers.
Marie Scandone, Database Product Manager, Bio-Rad Informatics commented, "We have carefully designed these new collections by focusing on specific chemical classes of compounds."
"In doing so, researchers now have an even wider selection of libraries from which to choose those that are most relevant to their studies."
"New collections also of note are the Explosive Materials and HAZMAT databases. Both databases could be used by researchers to identify potentially hazardous and dangerous substances."
"With the release of these databases, Bio-Rad continues their long-standing commitment in providing high-quality, comprehensive spectral data collections to the scientific community," said Ms. Scandone.
Avacta Group plc announces successful outcome of “Gene Delivery” collaboration with FIT BiotechNews
Sustained production of Affimer drugs by muscle tissue in vivo could lead to major patient and commercial benefits.READ MORE
XenoGesis and BioAscent Forge Alliance to Offer Enhanced Integrated Drug Discovery ServicesNews
XenoGesis and BioAscent Discovery Limited have announced a collaboration to offer an enhanced range of integrated drug discovery services, including medicinal chemistry, biology and DMPK.READ MORE
BioAscent Establishes Integrated Drug Discovery Services OfferingNews
Dr Phil Jones to join as new CSO to lead company’s extended capabilities in medicinal chemistry and in vitro biosciences.READ MORE